Linda Marts

Linda Marts practices at Laboratory Corporation of America in Zephyrhills, Florida.

Linda Marts' NPI, 1386053056, was assigned on August 7, 2014. Linda Marts holds Florida license APRN11014180.

Linda Marts' primary practice is Laboratory Corporation of America, at 5611 St, Zephyrhills, FL 33542 in Pasco County. The practice phone is (800) 877-5227.

Linda Marts' primary practice is Laboratory Corporation of America in Zephyrhills, Florida. The medical group on file is Kayenta Alternative Rural Hospital. Dmand AI also links Linda Marts to 3 more medical groups, 2 group practices and clinics, 1 community health center and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Linda Marts practices, 4 sites in all. Vendor and product names are available with a free account.

Family is Linda Marts' primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Linda Marts is board certified in family nurse practitioner by the American Academy of Nurse Practitioners Certification Program (AANPCP). Dmand AI has Linda Marts' licenses on file in 4 states: Florida, Arizona, Georgia and West Virginia.

Dmand AI lists acute skin infection, contact dermatitis, diabetic emergency, joint pain, lower back pain and upper respiratory infection (URI) among the conditions Linda Marts treats.

CMS data shows 15 Medicare services from Linda Marts across 1 procedure code in 2024, all of them office visits, for 18 Medicare patients. Medicare paid $717 for them. Every service was in an office.

CMS counts 18 Medicare patients who saw Linda Marts in 2024. The largest group is under 65, with 0 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Linda Marts' median patient age at 78, with 56% women.

In 2024, Linda Marts wrote 3,435 Medicare Part D claims for 1,204 patients. 87% of them were for generic drugs. CMS names the drug for 2,794 of them, across 80 drugs with 11 or more claims each, at $199,380 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Linda Marts for performance year 2024, reported as part of a group. Linda Marts accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Linda Marts is a member of AANP.